Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients

被引：15

作者：

Oliva, Stefania ^{[1
]}

Genuardi, Elisa ^{[1
]}

Belotti, Angelo ^{[1
]}

Frascione, Pio Manlio Mirko ^{[1
]}

Galli, Monica ^{[1
]}

Capra, Andrea ^{[1
]}

Offidani, Massimo ^{[1
]}

Vozella, Federico ^{[1
]}

Zambello, Renato ^{[1
]}

Auclair, Daniel ^{[2
]}

Siniscalchi, Agostina ^{[1
]}

Yesil, Jennifer ^{[2
]}

Annibali, Ombretta ^{[1
]}

Kirsch, Ilan M. ^{[3
]}

Caltagirone, Simona ^{[1
]}

Jacob, Allison P. ^{[3
]}

Ballanti, Stelvio ^{[1
]}

Palmas, Angelo D. ^{[1
]}

Ledda, Antonio ^{[1
]}

Corradini, Paolo ^{[1
]}

Omede, Paola ^{[1
]}

Cavo, Michele ^{[1
]}

Musto, Pellegrino ^{[1
]}

Boccadoro, Mario ^{[1
]}

Gay, Francesca

机构：

[1] European Myeloma Network, GIMEMA, Turin, Italy

[2] Multiple Myeloma Res Fdn, Norwalk, CT USA

[3] Adapt Biotechnol, Seattle, WA USA

来源：

关键词：

D O I：

10.1182/blood-2019-124645

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4322

引用

页数：5